These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey. Smith SM; Uslaner JM; Cox CD; Huszar SL; Cannon CE; Vardigan JD; Eddins D; Toolan DM; Kandebo M; Yao L; Raheem IT; Schreier JD; Breslin MJ; Coleman PJ; Renger JJ Neuropharmacology; 2013 Jan; 64():215-23. PubMed ID: 22750078 [TBL] [Abstract][Full Text] [Related]
4. PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model. Giralt A; Saavedra A; Carretón O; Arumí H; Tyebji S; Alberch J; Pérez-Navarro E Hippocampus; 2013 Aug; 23(8):684-95. PubMed ID: 23576401 [TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase Targets for Cognitive Dysfunction and Schizophrenia--a New York Academy of Sciences Meeting. Zhang HT IDrugs; 2010 Mar; 13(3):166-8. PubMed ID: 20191432 [TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer's disease: a translational overview. Heckman PR; Wouters C; Prickaerts J Curr Pharm Des; 2015; 21(3):317-31. PubMed ID: 25159073 [TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterases in the central nervous system: implications in mood and cognitive disorders. Xu Y; Zhang HT; O'Donnell JM Handb Exp Pharmacol; 2011; (204):447-85. PubMed ID: 21695652 [TBL] [Abstract][Full Text] [Related]
9. Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Sierksma AS; Rutten K; Sydlik S; Rostamian S; Steinbusch HW; van den Hove DL; Prickaerts J Neuropharmacology; 2013 Jan; 64():124-36. PubMed ID: 22771768 [TBL] [Abstract][Full Text] [Related]
10. The Phosphodiesterase 10A Selective Inhibitor TAK-063 Improves Cognitive Functions Associated with Schizophrenia in Rodent Models. Shiraishi E; Suzuki K; Harada A; Suzuki N; Kimura H J Pharmacol Exp Ther; 2016 Mar; 356(3):587-95. PubMed ID: 26675680 [TBL] [Abstract][Full Text] [Related]
11. Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future. Uckert S; Hedlund P; Andersson KE; Truss MC; Jonas U; Stief CG Eur Urol; 2006 Dec; 50(6):1194-207; discussion 1207. PubMed ID: 16815627 [TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase type 5 inhibition improves early memory consolidation of object information. Prickaerts J; Sik A; van Staveren WC; Koopmans G; Steinbusch HW; van der Staay FJ; de Vente J; Blokland A Neurochem Int; 2004 Nov; 45(6):915-28. PubMed ID: 15312986 [TBL] [Abstract][Full Text] [Related]
17. Opportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases. Li Q; Liao Q; Qi S; Huang H; He S; Lyu W; Liang J; Qin H; Cheng Z; Yu F; Dong X; Wang Z; Han L; Han Y Eur J Med Chem; 2024 May; 271():116386. PubMed ID: 38614063 [TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase 10A inhibitors: a novel approach to the treatment of the symptoms of schizophrenia. Menniti FS; Chappie TA; Humphrey JM; Schmidt CJ Curr Opin Investig Drugs; 2007 Jan; 8(1):54-9. PubMed ID: 17263185 [TBL] [Abstract][Full Text] [Related]
19. Herbs to curb cyclic nucleotide phosphodiesterase and their potential role in Alzheimer's disease. Kumar A; Sharma V; Singh VP; Kaundal M; Gupta MK; Bariwal J; Deshmukh R Mech Ageing Dev; 2015 Jul; 149():75-87. PubMed ID: 26050556 [TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase inhibitors as potential cognition enhancing agents. Schmidt CJ Curr Top Med Chem; 2010; 10(2):222-30. PubMed ID: 20166957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]